US Stock MarketDetailed Quotes

HUMA Humacyte

Watchlist
  • 2.875
  • -0.445-13.40%
Close Mar 25 16:00 ET
  • 2.200
  • -0.675-23.48%
Pre 05:48 ET
369.92MMarket Cap-2.15P/E (TTM)

Humacyte Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Humacyte Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 4 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 800.250K--
--2024/Q4-- / 0.000--
Nov 8, 20242024/Q30.000 / 0.000--
Aug 13, 20242024/Q20.000 / 0.000--
May 10, 20242024/Q10.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 800.250K--
--2024/Q4-- / 0.000--
Nov 8, 20242024/Q30.000 / 0.000--
Aug 13, 20242024/Q20.000 / 0.000--
May 10, 20242024/Q10.000 / 0.000--

Unlock Free Earnings Estimates

Humacyte Earnings Reports

  • 10-Q: Q3 2024 Earnings Report

    Nov 8, 2024 16:20 ET

  • 10-Q: Q2 2024 Earnings Report

    Aug 13, 2024 16:53 ET

  • 10-Q: Q1 2024 Earnings Report

    May 13, 2024 16:15 ET

  • Humacyte | 10-K: FY2023 Annual Report

    Mar 28, 2024 08:09 ET

    • Read more

    Market Insights
    Best Growth Stocks Best Growth Stocks

    Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

    Symbol Mini Chart % Chg
    Enerpac Tool
    EPAC
    +8.39%
    Precision Drilling
    PDS
    +2.04%
    Halozyme Therapeutics
    HALO
    +1.28%
    Workday
    WDAY
    +1.17%
    Lantheus
    LNTH
    +0.33%

    Unlock the Full List

    Analysis

    Analyst Rating

    Updated: Mar 20, 2025

    Strong Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data